Jagsonpal Pharma Sets Sep 4 Record Date for ₹4 Dividend

Jagsonpal Pharmaceuticals Ltd has announced September 04, 2026, as the record date for determining shareholder entitlement to a proposed dividend of ₹4 per equity share (200%) for the financial year ended March 31, 2026. The dividend recommendation was made by the Board of Directors on April 27, 2026, and is subject to shareholder approval at the 47th Annual General Meeting (AGM) scheduled for September 18, 2026. The AGM will be conducted via Video Conferencing. If approved, the dividend will be paid within 30 days of declaration, after deducting applicable taxes.